UA89712U - Method for treating osteoporosis in patients with systemic lupus erythematosus - Google Patents

Method for treating osteoporosis in patients with systemic lupus erythematosus

Info

Publication number
UA89712U
UA89712U UAU201314523U UAU201314523U UA89712U UA 89712 U UA89712 U UA 89712U UA U201314523 U UAU201314523 U UA U201314523U UA U201314523 U UAU201314523 U UA U201314523U UA 89712 U UA89712 U UA 89712U
Authority
UA
Ukraine
Prior art keywords
day
patients
lupus erythematosus
systemic lupus
treating osteoporosis
Prior art date
Application number
UAU201314523U
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Сергій Вікторович Шевчук
Віктор Іванович Шевчук
Original Assignee
Научно-Исследовательский Институт Реабилитации Инвалидов (Учебно-Научно-Лечебный Комплекс) Винницкого Национального Медицинского Университета Им. Н.И. Пирогова
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Научно-Исследовательский Институт Реабилитации Инвалидов (Учебно-Научно-Лечебный Комплекс) Винницкого Национального Медицинского Университета Им. Н.И. Пирогова filed Critical Научно-Исследовательский Институт Реабилитации Инвалидов (Учебно-Научно-Лечебный Комплекс) Винницкого Национального Медицинского Университета Им. Н.И. Пирогова
Priority to UAU201314523U priority Critical patent/UA89712U/en
Publication of UA89712U publication Critical patent/UA89712U/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The method for treating osteoporosis in the patients with systemic lupus erythematosus comprises the use of calcium-containing drugs, vitamin D and the assay for homocysteine and transforming factor growth beta 1. If homocysteine content exceeds 15 µM and TGF-(1 is below 14 ng/mL, Ostegenon is provided at a dose of 2 tablets thrice a day for three months, then one tablet thrice a day for further three months and Decamevit is provided at a dose of one tablet twice a day, 20-day courses with 5-day intervals.
UAU201314523U 2013-12-11 2013-12-11 Method for treating osteoporosis in patients with systemic lupus erythematosus UA89712U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201314523U UA89712U (en) 2013-12-11 2013-12-11 Method for treating osteoporosis in patients with systemic lupus erythematosus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201314523U UA89712U (en) 2013-12-11 2013-12-11 Method for treating osteoporosis in patients with systemic lupus erythematosus

Publications (1)

Publication Number Publication Date
UA89712U true UA89712U (en) 2014-04-25

Family

ID=52282151

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201314523U UA89712U (en) 2013-12-11 2013-12-11 Method for treating osteoporosis in patients with systemic lupus erythematosus

Country Status (1)

Country Link
UA (1) UA89712U (en)

Similar Documents

Publication Publication Date Title
MX2019007956A (en) Self-regulated release of active pharmaceutical ingredient.
UA89712U (en) Method for treating osteoporosis in patients with systemic lupus erythematosus
UA90083U (en) Method for treating osteoporosis in patients with systemic lupus erythematosus
UA90082U (en) Method for treating osteoporosis in patients with systemic lupus erythematosus
Craig Very-low-dose methadone for the prevention of opioid hyperalgesia.
Schmalbach Citrates/rituximab
Quirini Bendamustine/rituximab
UA62795U (en) Method for preventing cataract in patients with keratitis
UA70710U (en) Method for preventing recurrence of allergodermatosis in patients with secondary immunodeficiencies
UA66404U (en) Method for preventing and treating osteoporosis in pregnant patients with perinatal infection
UA91904U (en) Method for treating mycosis of feet
UA74059U (en) Method for complex treatment of echinococcus disease
UA93481U (en) Method for treating erythematous form of rosacea
UA90053U (en) Method for predicting risk of osteoporosis in patients with systemic lupus erythematosus
UA103397U (en) A method of treating chronic trichomoniasis
UA80927U (en) Method for preventing placental insufficiency in pregnant patients recovered from chronic infection
UA84284U (en) Method for treating mononucleosis in adult patients
UA112973U (en) METHOD OF MEDICAL REHABILITATION OF SPORTSMEN WHO TAKE INTENSIVE PHYSICAL LOADS, WITH THE SIGNIFICANCE OF IMMUNODEFICITIS AND ENDOGENOCOGENIC
UA93428U (en) Method for treating high grade of lipidemia
MD667Y (en) Method for treatment of infectious mononucleosis in children
UA88668U (en) Method for treating ischemic heart disease with concomitant metabolic syndrome in setting of vitamin d deficiency
UA103632U (en) Method for complex treatment of patients with anxious depression
UA82687U (en) Method for treatment of hypoporosis and false joints of bones
UA83970U (en) Method for treatmen of hyperhomocysteinemy
UA89824U (en) Method for medicamentous treatment of generalized periodontitis